1. Home
  2. LNN vs AGIO Comparison

LNN vs AGIO Comparison

Compare LNN & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNN
  • AGIO
  • Stock Information
  • Founded
  • LNN 1954
  • AGIO 2007
  • Country
  • LNN United States
  • AGIO United States
  • Employees
  • LNN N/A
  • AGIO N/A
  • Industry
  • LNN Industrial Machinery/Components
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNN Industrials
  • AGIO Health Care
  • Exchange
  • LNN Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • LNN 1.5B
  • AGIO 1.4B
  • IPO Year
  • LNN 1988
  • AGIO 2013
  • Fundamental
  • Price
  • LNN $133.27
  • AGIO $35.00
  • Analyst Decision
  • LNN Hold
  • AGIO Buy
  • Analyst Count
  • LNN 1
  • AGIO 6
  • Target Price
  • LNN $136.00
  • AGIO $57.40
  • AVG Volume (30 Days)
  • LNN 139.0K
  • AGIO 840.6K
  • Earning Date
  • LNN 06-26-2025
  • AGIO 07-31-2025
  • Dividend Yield
  • LNN 1.08%
  • AGIO N/A
  • EPS Growth
  • LNN 5.71
  • AGIO N/A
  • EPS
  • LNN 6.96
  • AGIO 11.13
  • Revenue
  • LNN $677,807,000.00
  • AGIO $40,875,000.00
  • Revenue This Year
  • LNN $13.09
  • AGIO $18.94
  • Revenue Next Year
  • LNN N/A
  • AGIO $201.70
  • P/E Ratio
  • LNN $19.18
  • AGIO $3.15
  • Revenue Growth
  • LNN 9.46
  • AGIO 30.57
  • 52 Week Low
  • LNN $112.14
  • AGIO $23.42
  • 52 Week High
  • LNN $150.96
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • LNN 37.56
  • AGIO 38.99
  • Support Level
  • LNN $133.48
  • AGIO $37.09
  • Resistance Level
  • LNN $139.65
  • AGIO $39.12
  • Average True Range (ATR)
  • LNN 3.16
  • AGIO 1.78
  • MACD
  • LNN -0.46
  • AGIO -0.67
  • Stochastic Oscillator
  • LNN 6.04
  • AGIO 9.16

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: